Loss of heterozygosity at 5q21 in non-small cell lung cancer: a frequent event but without evidence of apc mutation
- PMID: 8943812
- DOI: 10.1002/(SICI)1096-9896(199609)180:1<33::AID-PATH642>3.0.CO;2-Y
Loss of heterozygosity at 5q21 in non-small cell lung cancer: a frequent event but without evidence of apc mutation
Abstract
Four genetic polymorphisms in the APC and MCC genes at chromosome 5q21 were analysed for loss of heterozygosity (LOH) in 97 primary squamous carcinomas and adenocarcinomas of the lung. LOH was identified in at least two polymorphic loci in 41 percent of informative cases. There was no significant difference in the frequency of LOH between squamous carcinomas and adenocarcinomas. Within the adenocarcinoma group, however, LOH appeared to be more common in tumours having a bronchial origin (5/9; 56 per cent) than in parenchymal adenocarcinoma (6/21; 29 per cent). All 32 tumours showing LOH at one or more polymorphic sites were examined for mutations in the mutation cluster region (MCR) of APC by single-strand conformational polymorphism (SSCP) analysis. Mutations were not detected in any of these cases. We therefore propose that it is likely that a tumour suppressor gene on 5q other than APC is involved in the pathogenesis of lung cancer.
Similar articles
-
Loss of heterozygosity on chromosome 5 in sporadic ovarian carcinoma is a late event and is not associated with mutations in APC at 5q21-22.Hum Mutat. 1994;3(3):283-91. doi: 10.1002/humu.1380030317. Hum Mutat. 1994. PMID: 8019564
-
Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer.Cancer Res. 1992 Apr 1;52(7):1996-9. Cancer Res. 1992. PMID: 1348017
-
Allelic deletion mapping on chromosome 5 in human carcinomas.Oncogene. 1996 Jan 4;12(1):97-102. Oncogene. 1996. PMID: 8552404
-
[Search for the tumor-suppressor gene(s) on chromosome 5q, which may play an important role for the progression of lung cancer].Nihon Rinsho. 1996 Feb;54(2):482-6. Nihon Rinsho. 1996. PMID: 8838101 Review. Japanese.
-
The molecular biology of lung cancer pathogenesis.Chest. 1993 Apr;103(4 Suppl):449S-456S. doi: 10.1378/chest.103.4_supplement.449s. Chest. 1993. PMID: 8462339 Review.
Cited by
-
Frequent loss of heterozygosity on chromosome 5 in non-small cell lung carcinoma.Mol Pathol. 2000 Aug;53(4):184-7. doi: 10.1136/mp.53.4.184. Mol Pathol. 2000. PMID: 11040940 Free PMC article.
-
Report on mutation in exon 15 of the APC gene in a case of brain metastasis.J Neurooncol. 2010 Mar;97(1):143-8. doi: 10.1007/s11060-009-0001-7. Epub 2009 Aug 27. J Neurooncol. 2010. PMID: 19711014
-
Combined analysis with copy number variation identifies risk loci in lung cancer.Biomed Res Int. 2014;2014:469103. doi: 10.1155/2014/469103. Epub 2014 Jul 1. Biomed Res Int. 2014. PMID: 25093167 Free PMC article.
-
Brain metastases from lung cancer show increased expression of DVL1, DVL3 and beta-catenin and down-regulation of E-cadherin.Int J Mol Sci. 2014 Jun 13;15(6):10635-51. doi: 10.3390/ijms150610635. Int J Mol Sci. 2014. PMID: 24933634 Free PMC article.
-
Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas: relationship with adenomatous polyposis coli and G(1)-to S-phase cell-cycle regulators.Am J Pathol. 2002 Nov;161(5):1619-34. doi: 10.1016/s0002-9440(10)64440-9. Am J Pathol. 2002. PMID: 12414510 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical